170098-88-1

Basic information

• Product Name: 1-Chloro-4-fluoro-2-Methyl-5-nitrobenzene
• Synonyms: 1-Chloro-4-fluoro-2-Methyl-5-nitrobenzene
• CAS NO: 170098-88-1
• Molecular Formula: C₇H₅ClFNO₂
• Molecular Weight: 189.5715032
• Mol File: 170098-88-1.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-Chloro-4-fluoro-2-Methyl-5-nitrobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Chloro-4-fluoro-2-Methyl-5-nitrobenzene(170098-88-1)
• EPA Substance Registry System: 1-Chloro-4-fluoro-2-Methyl-5-nitrobenzene(170098-88-1)

Safety Data

• Hazardous Substances Data: 170098-88-1(Hazardous Substances Data)

Usage

General Description

1-Chloro-4-fluoro-2-Methyl-5-nitrobenzene is an aromatic chemical compound with the molecular formula C7H6ClFNO2. It is a colorless to pale yellow liquid that is primarily used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 1-Chloro-4-fluoro-2-Methyl-5-nitrobenzene has potential applications in the manufacturing of dyes, polymers, and other organic compounds. Its chemical structure consists of a benzene ring with a chlorine atom, a fluorine atom, a methyl group, and a nitro group attached to various positions around the ring. It is important to handle this chemical with caution, as it can be harmful if inhaled, ingested, or in contact with skin.

Upstream product

• 33406-96-1 2-chloro-5-fluorotoluene 

Downstream Products

• 932374-54-4 1,1-dimethylethyl 4-[(4-chloro-5-methyl-2-nitrophenyl)amino]-1-piperidinecarboxylate 

Relevant articles and documents

(1,1, 1,3, 3, 3-HEXAFLUORO-2-HYDROXYPROPAN-2-YL) PHENYL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR USE FOR THE TREATMENT OF ATHEROSCLEROSIS

The present invention relates to (1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl derivatives having the general formula (I) to pharmaceutical compositions comprising the same and to the use of these (1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl

BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE

Compounds of Formula (I) and salts and solvates are provided; wherein R, R5, R6 and Q are defined as in the claims. Uses of the compounds for therapy, for example in the treatment of psychotic disorders and cognitive impairment, are also disclosed.

Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones

Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia, and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and Down's syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions, and inducing anesthesia are disclosed by administering to an animal in need of such treatment an alkyl or azido-substituted 1,4-dihydroquinoxaline-2,3-dione or pharmaceutically acceptable salts thereof, which have high binding to the glycine receptor.